John W Prineas1, John D E Parratt2. 1. Brain and Mind Centre, Department of Medicine, The University of Sydney, Camperdown, NSW, Australia. 2. Parratt Brain and Mind Centre, Department of Medicine, The University of Sydney, Camperdown, NSW, Australia and Department of Neurology, Royal North Shore Hospital, St Leonards, NSW, Australia.
Abstract
BACKGROUND: It is uncertain whether there are autoantibodies detectable by indirect immunofluorescence in the serum of patients with multiple sclerosis (MS). OBJECTIVE: To determine whether there are anti-central nervous system (CNS) autoantibodies detectable by indirect immunofluorescence in the serum of MS patients. METHODS: Sera and in some cases cerebrospinal fluid from 106 patients with multiple sclerosis, 156 patients with other neurological diseases, and 70 healthy control subjects were examined by indirect immunofluorescence using cryostat sections of rat cerebrum fixed by perfusion with paraformaldehyde. RESULTS: Autoantibodies were detected that recognized more than 30 neuronal, glial, and mesodermal structures in 28 of 106 MS cases. Most were also detected in patients with other related and unrelated neurological diseases and several were also found in healthy controls. Novel anti-CNS autoantibodies recognizing particular sets of interneurons were detected in both normal controls and in subjects with CNS diseases. INTERPRETATION: Serum anti-CNS autoantibodies of diverse specificities are common in MS patients. The same anti-CNS autoantibodies are not uncommon in patients with other neurological diseases. The findings provide no support for the proposition that myelin breakdown in MS is caused by exposure of intact myelin sheaths or oligodendrocytes to a pathogenic serum anti-myelin or anti-oligodendrocyte autoantibody.
BACKGROUND: It is uncertain whether there are autoantibodies detectable by indirect immunofluorescence in the serum of patients with multiple sclerosis (MS). OBJECTIVE: To determine whether there are anti-central nervous system (CNS) autoantibodies detectable by indirect immunofluorescence in the serum of MS patients. METHODS: Sera and in some cases cerebrospinal fluid from 106 patients with multiple sclerosis, 156 patients with other neurological diseases, and 70 healthy control subjects were examined by indirect immunofluorescence using cryostat sections of rat cerebrum fixed by perfusion with paraformaldehyde. RESULTS: Autoantibodies were detected that recognized more than 30 neuronal, glial, and mesodermal structures in 28 of 106 MS cases. Most were also detected in patients with other related and unrelated neurological diseases and several were also found in healthy controls. Novel anti-CNS autoantibodies recognizing particular sets of interneurons were detected in both normal controls and in subjects with CNS diseases. INTERPRETATION: Serum anti-CNS autoantibodies of diverse specificities are common in MS patients. The same anti-CNS autoantibodies are not uncommon in patients with other neurological diseases. The findings provide no support for the proposition that myelin breakdown in MS is caused by exposure of intact myelin sheaths or oligodendrocytes to a pathogenic serum anti-myelin or anti-oligodendrocyte autoantibody.
Authors: Stefanie Kuerten; Tobias V Lanz; Nithya Lingampalli; Lauren J Lahey; Christoph Kleinschnitz; Mathias Mäurer; Michael Schroeter; Stefan Braune; Tjalf Ziemssen; Peggy P Ho; William H Robinson; Lawrence Steinman Journal: Proc Natl Acad Sci U S A Date: 2020-08-18 Impact factor: 11.205
Authors: Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze Journal: Metab Brain Dis Date: 2021-04-28 Impact factor: 3.584
Authors: Stephanie Trend; Anderson P Jones; Lilian Cha; Scott N Byrne; Sian Geldenhuys; Marzena J Fabis-Pedrini; William M Carroll; Judith M Cole; David R Booth; Robyn M Lucas; Allan G Kermode; Martyn A French; Prue H Hart Journal: Front Immunol Date: 2018-07-13 Impact factor: 7.561
Authors: Raymond A Sobel; Mary Jane Eaton; Prajakta Dilip Jaju; Eugene Lowry; Julian R Hinojoza Journal: J Neuropathol Exp Neurol Date: 2019-09-01 Impact factor: 3.685
Authors: Susan J van Rensburg; Armand V Peeters; Ronald van Toorn; Johan Schoeman; Kelebogile E Moremi; Carel J van Heerden; Maritha J Kotze Journal: Mol Genet Metab Rep Date: 2019-03-23